Emerging applications of tumour-educated platelets in the detection and prognostication of ovarian cancer

doi:10.1093/procel/pwad015

Protein Cell

2023, Vol. 14

Issue (8) : 556-559 https://doi.org/10.1093/procel/pwad015

COMMENTARY

Emerging applications of tumour-educated platelets in the detection and prognostication of ovarian cancer

Jiewei Zhu^1,², Vasily Giannakeas¹, Steven A. Narod^1,^3,⁴, Mohammad R. Akbari^1,^3,⁴(

)

¹. Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, Ontario M5S 1B2, Canada
². Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A, Canada
³. Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A, Canada
⁴. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario M5S 1A, Canada

Download: PDF(701 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Corresponding Author(s): Mohammad R. Akbari

Issue Date: 26 September 2023

Cite this article:

Jiewei Zhu,Vasily Giannakeas,Steven A. Narod, et al. Emerging applications of tumour-educated platelets in the detection and prognostication of ovarian cancer[J]. Protein Cell, 2023, 14(8): 556-559.

URL:

https://academic.hep.com.cn/pac/EN/10.1093/procel/pwad015
https://academic.hep.com.cn/pac/EN/Y2023/V14/I8/556

1	M Antunes-Ferreira, D Koppers-Lalic, T. Würdinger Circulating platelets as liquid biopsy sources for cancer detection. Mol Oncol 2021;15:1727–1743. https://doi.org/10.1002/1878-0261.12859
2	SGJG Veld, M Arkani, E Post et al. Detection and localization of early- and late-stage cancers using platelet RNA. Cancer Cell 2022;40:999–1009.e6.
3	L Chen, K Wang, L Li et al. Plasma exosomal miR-1260a, miR-7977 and miR-192-5p as diagnostic biomarkers in epithelial ovarian cancer. Future Oncol 2022;18:2919–2931. https://doi.org/10.2217/fon-2022-0321
4	M Dovizio, P Ballerini, R Fullone et al. Multifaceted functions of platelets in cancer: from tumorigenesis to liquid biopsy tool and drug delivery system. Int J Mol Sci 2020;21:9585. https://doi.org/10.3390/ijms21249585
5	Y Gao, CJ Liu, HY Li et al. Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study. Protein Cell 2022. https://doi.org/10.1093/procel/pwac056
6	V. Giannakeas Trends in platelet count among cancer patients. Exp Hematol Oncol 2022;11:16. https://doi.org/10.1186/s40164-022-00272-3
7	CJ Liu, HY Li, Y Gao et al. Platelet RNA signature independently predicts ovarian cancer prognosis by deep learning neural network model. Protein Cell 2022. https://doi.org/10.1093/procel/pwac053
8	M Lomnytska, R Pinto, S Becker et al. Platelet protein biomarker panel for ovarian cancer diagnosis. Biomark Res 2018;6:2. https://doi.org/10.1186/s40364-018-0118-y
9	F Passiglia, S Rizzo, M Di Maio et al. The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis [published correction appears in Sci Rep. 2018 Nov 19;8(1):17270]. Sci Rep 2018;8:13379. https://doi.org/10.1038/s41598-018-30780-4
10	J Piek, S In ’t Veld, M Best et al. EP457 assessment of ovarian tumors with tumor-educated platelets (TEPs). Int J Gynecol Cancer 2019;29:A291. https://doi.org/10.1136/ijgc-2019-ESGO.516
11	B Psaila, G Wang, A Rodriguez-Meira et al.; NIH Intramural Sequencing Center. Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets. Mol Cell 2020;78:477–492.e8. https://doi.org/10.1016/j.molcel.2020.04.008
12	R Sabatier, S Garnier, A Guille et al. Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial. Front Oncol 2022;12:946257. https://doi.org/10.3389/fonc.2022.946257
13	RL Siegel, KD Miller, HE Fuchs et al. Cancer Statistics, 2021. CA Cancer J Clin 2021;71:7–33. https://doi.org/10.3322/caac.21654
14	N Sol, T. Wurdinger Platelet RNA signatures for the detection of cancer. Cancer Metastasis Rev 2017;36:263–272. https://doi.org/10.1007/s10555-017-9674-0
15	R Stone, A Nick, I McNeish et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 2012;366:610–618. https://doi.org/10.1056/NEJMoa1110352
16	T Wang, Y Gao, Xi Wang et al. Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics. Chin J Cancer Res 2022;34:95–108. https://doi.org/10.21147/j.issn.1000-9604.2022.02.04
17	JW Zhu, P Charkhchi, MR. Akbari Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer 2022;21:114. https://doi.org/10.1186/s12943-022-01588-8

[1]

PAC-0556-22639-AM_suppl_1

Download

Viewed

Full text

Abstract

Cited

Shared

Discussed